Terms: = Endocrine gland cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
20 results:
1. Machine learning developed a fibroblast-related signature for predicting clinical outcome and drug sensitivity in ovarian cancer.
Fu W; Feng Q; Tao R
Medicine (Baltimore); 2024 Apr; 103(16):e37783. PubMed ID: 38640321
[TBL] [Abstract] [Full Text] [Related]
2. [
Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
[TBL] [Abstract] [Full Text] [Related]
3. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract] [Full Text] [Related]
4. Machine learning developed a CD8
Chen R; Zheng Y; Fei C; Ye J; Fei H
Sci Rep; 2024 Mar; 14(1):5794. PubMed ID: 38461331
[TBL] [Abstract] [Full Text] [Related]
5. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
Huang Y; Gong P; Su L; Zhang M
Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning developed a PI3K/Akt pathway-related signature for predicting prognosis and drug sensitivity in ovarian cancer.
Han X; Yang L; Tian H; Ji Y
Aging (Albany NY); 2023 Oct; 15(20):11162-11183. PubMed ID: 37851341
[TBL] [Abstract] [Full Text] [Related]
7. A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance.
Chen L; Gao W; Lin L; Sha C; Li T; Chen Q; Wei H; Yang M; Xing J; Zhang M; Zhao S; Xu W; Li Y; Long L; Zhu X
J Ovarian Res; 2023 Sep; 16(1):186. PubMed ID: 37674251
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights.
Balsano R; Zanuso V; Pirozzi A; Rimassa L; Bozzarelli S
Curr Oncol; 2023 Mar; 30(4):3871-3885. PubMed ID: 37185406
[TBL] [Abstract] [Full Text] [Related]
9. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma.
Xu X; Sun T; Jing J
BMC Endocr Disord; 2022 Nov; 22(1):280. PubMed ID: 36380313
[TBL] [Abstract] [Full Text] [Related]
10. Exoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a retrospective single-center study on 388 patients.
Sumisławski P; Piffko A; Huckhagel T; Ryba A; Burkhardt T; Aberle J; Saeger W; Flitsch J; Rotermund R
Neurosurg Rev; 2022 Dec; 45(6):3675-3681. PubMed ID: 36136255
[TBL] [Abstract] [Full Text] [Related]
11. ctla-4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer.
Chen J; Kang S; Wu J; Zhao J; Si W; Sun H; Li Y
J Obstet Gynaecol Res; 2022 May; 48(5):1240-1247. PubMed ID: 35150042
[TBL] [Abstract] [Full Text] [Related]
12. Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian cancer Patients.
Liu J; Wang Y; Yuan S; Wei J; Bai J
Front Immunol; 2021; 12():751594. PubMed ID: 34745124
[TBL] [Abstract] [Full Text] [Related]
13. ctla-4 blockade boosts the expansion of tumor-reactive CD8
Friese C; Harbst K; Borch TH; Westergaard MCW; Pedersen M; Kverneland A; Jönsson G; Donia M; Svane IM; Met Ö
Sci Rep; 2020 Mar; 10(1):3914. PubMed ID: 32127601
[TBL] [Abstract] [Full Text] [Related]
14. Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing's syndrome.
Andereggen L; Gralla J; Schroth G; Mordasini P; Andres RH; Widmer HR; Luedi MM; Kellner F; Beck J; Mariani L; Ozdoba C; Christ E
J Neuroradiol; 2021 Feb; 48(1):10-15. PubMed ID: 31228539
[TBL] [Abstract] [Full Text] [Related]
15. Solid pseudopapillary tumor of the pancreas: A retrospective analysis of 36 cases from a single institution in India.
Singh P; Patel K; Ramakrishna B
Indian J Cancer; 2015; 52(3):439-42. PubMed ID: 26905162
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma.
Siamakpour-Reihani S; Owzar K; Jiang C; Turner T; Deng Y; Bean SM; Horton JK; Berchuck A; Marks JR; Dewhirst MW; Alvarez Secord A
Gynecol Oncol; 2015 Oct; 139(1):23-9. PubMed ID: 26260910
[TBL] [Abstract] [Full Text] [Related]
17. Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients.
Costello A; Rey-Hipolito C; Patel A; Oakley K; Vasco V; Calabria C; Tuttle RM; Francis GL
Thyroid; 2005 Feb; 15(2):105-13. PubMed ID: 15753667
[TBL] [Abstract] [Full Text] [Related]
18. Interferon-gamma expression is an independent prognostic factor in ovarian cancer.
Marth C; Fiegl H; Zeimet AG; Müller-Holzner E; Deibl M; Doppler W; Daxenbichler G
Am J Obstet Gynecol; 2004 Nov; 191(5):1598-605. PubMed ID: 15547530
[TBL] [Abstract] [Full Text] [Related]
19. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
Chen JC; Amar AP; Choi S; Singer P; Couldwell WT; Weiss MH
J Neurosurg; 2003 May; 98(5):967-73. PubMed ID: 12744355
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome.
von Wasielewski R; Rhein A; Werner M; Scheumann GF; Dralle H; Pötter E; Brabant G; Georgii A
Cancer Res; 1997 Jun; 57(12):2501-7. PubMed ID: 9192832
[TBL] [Abstract] [Full Text] [Related]
